The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart. https://t.co/BveqsrwIXp
RT @MelindaCoughlan: 👇🏻👇🏻👇🏻 Our new study testing a mitochondria targeted methylglyoxal scavenger is out! Mitogamide is cardioprotective in…
RT @MelindaCoughlan: 👇🏻👇🏻👇🏻 Our new study testing a mitochondria targeted methylglyoxal scavenger is out! Mitogamide is cardioprotective in…
RT @MelindaCoughlan: 👇🏻👇🏻👇🏻 Our new study testing a mitochondria targeted methylglyoxal scavenger is out! Mitogamide is cardioprotective in…
RT @MelindaCoughlan: 👇🏻👇🏻👇🏻 Our new study testing a mitochondria targeted methylglyoxal scavenger is out! Mitogamide is cardioprotective in…
👇🏻👇🏻👇🏻 Our new study testing a mitochondria targeted methylglyoxal scavenger is out! Mitogamide is cardioprotective in the diabetic heart. Great team work @rebeccahritchie @MIPS_Australia @MitchelTate1 @MilesDeBlasio @BakerResearchAu @Cambridge_Uni Mike M
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart. https://t.co/BveqsrwIXp